Likely due to a greater use of next-generation sequencing technologies by NICs globally, as well as, new initiatives (e.g. the Influenza Monitoring Vaccine Effectiveness (I-MOVE) program in Europe, Advanced Molecular Detection (AMD) in the USA) greater numbers of NA sequences are being deposited in databases. This evidence concerns the gene XK and influenza.